Nuvation Bio (NUVB) Stock Highlights

2.68 | -0.37%

2024-12-21 04:37:44

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The companys proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.

Statistics

Range Today

2.57 2.76

Volume Today 9.24M

Range 1 Year

1.39 4.16

Volume 1 Year 390.5M

Range 3 Year

0.95 8.88

Volume 3 Year 810.03M

Range 10 Year

0.95 15.23

Volume 10 Year 1.02B

Highlights

Market Capitalization 969.31M (small)

Floating Shares 189.61M

Current Price 2.68

Price To Earnings -1.22

Price To Revenue 115.6

Price To Book 1.57

Earnings Per Share -2.4

Payout Ratio 0%

Performance

Latest -0.37%

1 Month +3.08%

3 Months -8.22%

6 Months -7.59%

1 Year +83.56%

3 Years -68.06%

5 Years -73.47%

10 Years -73.47%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.